Ningbo Rongyu Biological Pharmaceutical

Ningbo Rongyu Biological Pharmaceutical is a specialized biopharmaceutical company based in China that focuses on the research, development, and large-scale production of high-end complex injectable formulations. The company leverages advanced drug delivery technologies, including liposomes, microspheres, and nanocrystals, to enhance the therapeutic profile of critical medicines. Its lead commercial product is an Iron Sucrose Injection used for the treatment of iron deficiency anemia. Rongyu Bio operates state-of-the-art GMP manufacturing facilities in the Ningbo Free Trade Zone, positioning itself as both a product developer and a high-end contract manufacturer. The company's pipeline primarily targets oncology, hematology, and anti-infective therapeutic areas through improved generic and innovative formulations.